 | Up a level |
Journal Article
Faehling, M., Schumann, C., Christopoulos, P., Hoffknecht, P., Alt, J., Horn, M., Eisenmann, S., Schlenska-Lange, A., Aries, S. P., Sackmann, S., Schuett, P., Steger, F. and Christoph, D. (2020). Durvalumab after definitive radiochemotherapy (RCT) in locally advanced unresectable NSCLC: Real-world data on survival and safety from the German expanded access program (EAP). Ann. Oncol., 31. S. S806 - 2. AMSTERDAM: ELSEVIER. ISSN 1569-8041
Frost, N., Christopoulos, P., Kauffmann-Guerrero, D., Stratmann, J. A., Riedel, R., Schaefer, M., Alt, J., Guetz, S., Brinkmann, J. and Griesinger, F. (2020). Lorlatinib in pretreated ALK/ROS1-positive non-small cell lung cancer (NSCLC): Results from the German early access program. Ann. Oncol., 31. S. S874 - 1. AMSTERDAM: ELSEVIER. ISSN 1569-8041